The results showed that USP15 mRNA and protein levels were markedly decreased in PBMCs of CML-BC patients (n = 6) compared with age-matched CML-CP patients (n = 6) (Fig. 2 d and e). This evidence concerns the gene USP15 and chronic myelogenous leukemia, BCR-ABL1 positive.